Rushnet's Subsidiary heliosDX Launches Human Monkepox Virus Testing, Available Immediately

Author's Avatar
Aug 09, 2022

ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner laboratory effective today.